is the first device in cardiology to receive a “breakthrough” designation by the Food and Drug Administration.
For many patients with heart failure who are already on the right medications, there’s not much else they can do unless they decide to undergo open-heart surgery to place a mechanical pump inside. The new device, however, called the and approved by the FDA on March 21, is a device that can improve advanced stages of the disease by helping the heart squeeze more effectively.in the United States. As the heart’s ability to pump blood to the rest of the body deteriorates, the heart becomes unable to squeeze and fluid builds up in the body. This fluid can accumulate in the lungs, causing shortness of breath, or throughout the tissues of the body, causing generalized swelling.
And it only costs ONE MILLION DOLLARS. How much Ad revenue does ABC earn from the drug and death industry?
How much ya wanna bet this is gonna be hella overpriced?
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Rejects Oral Treatment for Type 1 DiabetesLexicon Pharmaceuticals is developing the treatment, which is called Zynquista, with French pharmaceutical giant Sanofi. Buena decisión. Pending House Legislation requiring Medicare to negotiate drug prices requires HHS to favor domestic manufacturers over foreign ones, If they don't already have them, foreign companies would be forced to build/buy manufacturing facilities here. Follow the $$.
Source: WSJ - 🏆 98. / 63 Read more »
Jazz Pharma's sleep disorder treatment gets FDA nodThe U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's t... Wait what - same drug solriamfetol will work for OSA and Narcolepsy. This doesn’t sound right; these are very different sleep disorders. The same drug to cure both OSA (Breathing) and Narcolepsy (Braincells) ? Think this story has to be looked at again. It also refers to Xyrem users as being ‘invalid’ ‘Invalid’ with regards to what exactly? RT : Jazz Pharma's sleep disorder treatment gets FDA nod
Source: Reuters - 🏆 2. / 97 Read more »
Sage Therapeutics’ Drug for Postpartum Depression Gets FDA NodU.S. health regulators on Tuesday approved Sage Therapeutics Inc.’s Zulresso, the first medication specifically intended for women with postpartum depression. Really? We need yet another drug to make a fortune for Pharma & who knows what side effects? Yes, I know PPD is serious & it’s likely _some_ ppl need meds. Shd be a more holistic solution: therapy, help home, 24/7 access to a known midwife, not just throw meds the problem Side effects?
Source: WSJ - 🏆 98. / 63 Read more »
FDA approves first treatment for postpartum depressionThe FDA has approved a new medication called Zulresso, a completely new class of drug designed specifically to treat postpartum depression. It’s a one-time infusion given in a hospital over two and a half days. Wow your born and time soviebe bebies Oh. I don't think I'd want to be breastfeeding with that in my system. Hey anything to keep women from killing there kids. It’s apparently a mental disorder.
Source: NBCNews - 🏆 10. / 86 Read more »